
Endo Vision
Endo's vision is to become a premier specialty pharmaceutical company anchored in pain management with a balanced focus in complementary therapeutic areas.
Endo's Values
Our employees share our values by taking ownership of the technology and delivery systems that support our vision. They are a resourceful and innovative team who stay focused on positive results. We are committed to providing a rich cultural environment to successfully grow our business within the healthcare community.

Comming Soon!



DEPODUR® (MORPHINE SULFATE EXTENDED-RELEASE LIPOSOME INJECTION) |
View PDF |
FROVA® (FROVATRIPTAN SUCCINATE) TABLETS |
View PDF |
LIDODERM® PATCH |
View PDF |
OPANA® (OXYMORPHONE HCI) IMMEDIATE-RELEASE TABLETS CII |
View PDF |
OPANA® (OXYMORPHONE HCI) INJECTION |
View PDF |
OPANA® ER (OXYMORPHONE HCI) EXTENDED-RELEASE TABLETS CII |
View PDF |
PERCOCET® 10/325 MG TABLETS CII |
View PDF |
PERCOCET® 10/650 MG TABLETS CII |
View PDF |
PERCOCET® 2.5/325 MG TABLETS CII |
View PDF |
PERCOCET® 5/325 MG TABLETS CII |
View PDF |
PERCOCET® 7.5/325 MG TABLETS CII |
View PDF |
PERCOCET® 7.5/500 MG TABLETS CI |
View PDF |
PERCODAN® TABLETS CII |
View PDF |
SYNERA® (70 MG LIDOCAINE/70 MG TETRACAINE) TOPICAL PATCH |
View PDF |
ZYDONE® TABLETS CIII |
View PDF |


Direct: 1-166-245-3636 ext. 5422
Mobile: 480-203-6475
Fax: 480-473-8162
Email: mcNevin.lisa@endo.com